Fennec Pharmaceuticals Stock Forecast for 2023 - 2025 - 2030
Updated on 05/08/2024
Fennec Pharmaceuticals Stock Forecast and Price Target
The average price target of $18.00 for Fennec Pharmaceuticals's stock set by distinguished analysts in recent weeks would represent a potential upside of approximately 92.51% from the last closing price in May, 2024 if reached by the end of the year. This potential increase is based on a high estimate of $22.00 and a low estimate of $16.00.
92.51% Upside
Fennec Pharmaceuticals Fair Value Forecast for 2023 - 2025 - 2030
In the last three years, Fennec Pharmaceuticals's Price has grown, moving from $0.00 to $0.00 – an increase of 100.00%. In the next year, analysts predict that Fair Value will jump to $10.03 – up 100.00% from the current level. Looking ahead to seven years, experts forecast that Fair Value will grow by 100.00%.
Fennec Pharmaceuticals Revenue Forecast for 2023 - 2025 - 2030
In the last year, Fennec Pharmaceuticals's Revenue has grown, moving from $170.00k to $1.54M – an increase of 805.88%. In the next year, analysts predict that Revenue will jump to $44.00M – up 2757.14% from the current level. Looking ahead to seven years, experts forecast that Revenue will grow by 18140.26%.
.jpg)
Fennec Pharmaceuticals EBIT Forecast for 2023 - 2025 - 2030
Fennec Pharmaceuticals's EBIT has grown in the last two years, jumping from $-17.89M to $-22.59M – an increase of 26.27%. 6 analysts predict Fennec Pharmaceuticals's EBIT will decrease by 133.82% in the next year, reaching $7.64M. By 2030, professionals predict that Fennec Pharmaceuticals's EBIT will decrease by 854.76%, to $170.50M.
Fennec Pharmaceuticals EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last three years, Fennec Pharmaceuticals's EPS has grown, moving from $-0.76 to $0.00 – an increase of 100.00%. In the next year, analysts predict that EPS will jump to $0.23 – up 100.00% from the current level. Looking ahead to seven years, experts forecast that EPS will grow by 100.00%.
Site Navigation
.jpg)